Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: A quasi-experimental, before and after observational cohort study

The Lancet Infectious Diseases

Volumn 12, Issue 10, 2012, Pages 774-780

  Hranjec, Tjasa ^a   Rosenberger, Laura H ^a   Swenson, Brian ^a   Metzger, Rosemarie ^a   Flohr, Tanya R ^a   Politano, Amani D ^a   Riccio, Lin M ^a   Popovsky, Kimberley A ^a   Sawyer, Robert G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; AGGRESSIVE ANTIMICROBIAL THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; COHORT ANALYSIS; CONSERVATIVE ANTIMICROBIAL THERAPY; CONSERVATIVE TREATMENT; CRITICAL ILLNESS; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL WARD; THERAPY DELAY; TREATMENT DURATION; UNITED STATES;

ADULT; AGED; ANTI-INFECTIVE AGENTS; APACHE; CONFIDENCE INTERVALS; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84866608973     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70151-2     Document Type: Article

References (30)

1. Marik PE Fever in the ICU. Chest 2000, 117:855-869.
2. Barie PS, Hydo LJ, Eachempati SR Causes and consequences of fever complicating critical surgical illness. Surg Infect (Larchmt) 2004, 5:145-159.
3. Aarts MA, Brun-Buisson C, Cook DJ, et al. Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?. Intensive Care Med 2007, 33:1369-1378.
4. Koenig SM, Truwit JD Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 2006, 19:637-657.
5. Porzecanski I, Bowton DL Diagnosis and treatment of ventilator-associated pneumonia. Chest 2006, 130:597-604.
6. Kollef MH, Sherman G, Ward S, Fraser VJ Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
7. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
8. Leone M, Bourgoin A, Cambon S, et al. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003, 31:462-467.
9. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003, 31:2742-2751.
10. Clec'h C, Timsit JF, De Lassence A, et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity. Intensive Care Med 2004, 30:1327-1333.
11. Teixeira PJ, Seligman R, Hertz FT, et al. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes. J Hosp Infect 2007, 65:361-367.
12. Parkins MD, Sabuda DM, Elsayed S, Laupland KB Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007, 60:613-618.
13. Baughman RP Antibiotic resistance in the intensive care unit. Curr Opin Crit Care 2002, 8:430-434.
14. Stein GE Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures. Pharmacotherapy 2005, 25:S44-S54.
15. Salgado CD, O'Grady N, Farr BM Prevention and control of antimicrobial-resistant infections in intensive care patients. Crit Care Med 2005, 33:2373-2382.
16. French GL Clinical impact and relevance of antibiotic resistance. Adv Drug Deliv Rev 2005, 57:1514-1527.
17. Clark NM, Patterson J, Lynch JP Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care 2003, 9:413-423.
18. Clark NM, Hershberger E, Zervosc MJ, Lynch JP Antimicrobial resistance among gram-positive organisms in the intensive care unit. Curr Opin Crit Care 2003, 9:403-412.
19. Hughes MG, Chong TW, Smith RL, et al. Comparison of fungal and nonfungal infections in a broad-based surgical patient population. Surg Infect (Larchmt) 2005, 6:55-64.
20. Saalwachter AR, Hedrick T, Sawyer RG The other fungi: it's not just Candida albicans anymore. Surg Infect (Larchmt) 2006, 7:143-150.
21. Gleason TG, May AK, Caparelli D, et al. Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg 1997, 132:1197-1201.
22. Eggimann P, Garbino J, Pittet D Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003, 3:685-702.
23. Crabtree TD, Pelletier SJ, Gleason TG, et al. Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-associated diarrhea. Am Surg 1999, 65:507-511.
24. Marra AR, Edmond MB, Wenzel RP, Bearman GM Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis 2007, 7:42.
25. Pelletier SJ, Crabtree TD, Gleason TG, et al. Waiting for microbiologic data to direct therapy against nosocomial infections in febrile surgical patients: are outcomes worsened?. Arch Surg 1999, 134:1300-1307.
26. Hedrick TL, Evans HL, Smith RL, et al. Can we define the ideal duration of antibiotic therapy?. Surg Infect (Larchmt) 2006, 7:419-432.
27. Dancer SJ, Coyne M, Robertson C, et al. Antibiotic use is associated with resistance of environmental organisms in a teaching hospital. J Hosp Infect 2006, 62:200-206.
28. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
29. Raymond DP, Pelletier SJ, Crabtree TD, Evan HL, Pruett TL, Sawyer RG Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med 2003, 31:1035-1041.
30. Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 2005, 6:41-54.